Osiris Therapeutics Inc

Company Snapshot
7015 Albert Einstein Drive
Columbia, MD 21046-1707
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 217
http://www.osiris.com
Please select from the dropdown
Company Financials

2016
2017
2018
Gross Profit
$78,641,000
$85,833,000
$104,685,000
Operating Income
($4,096,000)
($1,989,000)
$10,753,000
Net Income
($3,749,000)
$8,785,000
$36,901,000
2016
Gross Profit
$78,641,000
Operating Income
($4,096,000)
Net Income
($3,749,000)
2017
Gross Profit
$85,833,000
Operating Income
($1,989,000)
Net Income
$8,785,000
2018
Gross Profit
$104,685,000
Operating Income
$10,753,000
Net Income
$36,901,000
The above data on Osiris Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Alla Danilkovitch
Chief Scientific Officer
$243,349
$221,689
$4,855
$469,893
Alla Danilkovitch
$469,893
Chief Scientific Officer
Jason Keefer
Interim President and Chief Executive Officer
$210,735
$71,197
$132,647
$414,579
Jason Keefer
$414,579
Interim President and Chief Executive Officer
Peter Friedli
Chairman of the Board
$150,000
$0
$0
$150,000
Peter Friedli
$150,000
Chairman of the Board
Thomas Brandt
Independent Director
$60,000
$0
$0
$60,000
Thomas Brandt
$60,000
Independent Director
Thomas Knapp
Independent Director
$53,918
$0
$0
$53,918
Thomas Knapp
$53,918
Independent Director
Osiris Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2017. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us